MRGN: new classification for multidrug-resistant Gram-negative bacteria

被引:0
|
作者
Kaase, Martin [1 ]
机构
[1] Ruhr Univ Bochum, Dept Med Microbiol, D-44801 Bochum, Germany
来源
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE | 2013年 / 37卷 / 06期
关键词
carbapenemases; Gram-negative bacteria; infection control; MRGN classification; multidrug-resistance; ANTIMICROBIAL SUSCEPTIBILITY; ESCHERICHIA-COLI; CARBAPENEMASES;
D O I
10.1515/labmed-2012-0067
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
New recommendations for infection control in the case of infection or colonization by multidrug-resistant Gram-negative bacteria were published by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch-Institute, Germany. In this context, a new definition for multidrug-resistance, the so-called MRGN classification, was introduced. This was necessary because previous definitions did not seem suitable for the purpose of hospital hygiene. The MRGN classification grades multidrug-resistance by severity distinguishing 3MRGN and 4MRGN, resulting in different recommendations for infection control. In addition, not all antibiotics are regarded equally important in the classification, but only most relevant classes, such as ureidopenicillins, extended-spectrum cephalosporins, carbapenems, and fluoroquinolones, are taken into account. The MRGN classification is mainly based on resistance categories, not on resistance mechanisms. An exception has been made for carbapenemase-producing Enterobacteriaceae, which are always classified as 4MRGN irrespective of their antibiogram due to their importance. The correct MRGN classification should only be performed by experienced microbiological laboratories and requires a reliable detection of carbapenemases.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [1] Antibiotics for multidrug-resistant gram-negative bacteria
    Kang, Cheol-In
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (08): : 490 - 497
  • [2] The Dilemma of Multidrug-Resistant Gram-Negative Bacteria
    Engel, Lee S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03): : 232 - 237
  • [3] New Antibiotics for the Treatment of multidrug-resistant gram-negative Bacteria
    Probst-Kepper, Michael
    Geginat, Gernot
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2018, 53 (7-8): : 529 - 542
  • [4] Epidemiological analysis of multidrug-resistant Gram-negative bacteria (MRGN) among haemato-oncological patients
    Gehring, S.
    Faerber, J.
    Fischer, T.
    Schalk, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 292 - 292
  • [5] Multidrug-resistant Gram-negative bacteria: a product of globalization
    Hawkey, P. M.
    JOURNAL OF HOSPITAL INFECTION, 2015, 89 (04) : 241 - 247
  • [6] Multidrug-Resistant Gram-Negative Bacteria in Burn Patients
    Ruegsegger, Laura
    Xiao, Jamie
    Naziripour, Arash
    Kanumuambidi, Trey
    Brown, Dylan
    Williams, Felicia
    Marshall, Steven H.
    Rudin, Susan D.
    Yen, Kelly
    Chu, Tingyu
    Chen, Liang
    Sozzi, Emanuele
    Bartelt, Luther
    Kreiswirth, Barry
    Bonomo, Robert A.
    van Duin, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [7] Multidrug-Resistant Gram-Negative Bacteria in Hematology and Oncology
    Schalk, Enrico
    Faeber, Jacqueline
    Fischer, Thomas
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (09): : 1203 - 1204
  • [8] Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
    Giacobbe, Daniele Roberto
    Karaiskos, Ilias
    ANTIBIOTICS-BASEL, 2020, 9 (04):
  • [9] Intravenous colistimethate for multidrug-resistant: Gram-negative bacteria
    Zavascki, Alexandre P.
    Li, Jian
    LANCET INFECTIOUS DISEASES, 2008, 8 (07): : 403 - 405
  • [10] Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
    Tiago Silva, Jose
    Lopez-Medrano, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 41 - 43